MedTrace Logo

The AT-REBOA Target Trial

NCT06312436 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2025-01-22

No results posted yet for this study

Summary

Temporary aortic occlusion can limit haemorrhage, can help to maintain perfusion to the heart and brain, and may be associated with improved survival. Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) potentially provides a relatively quick means of achieving this temporary control.

In the past years, studies have tried to evaluate the benefit for this method with conflicting results. The previous UK-REBOA trial has not found any benefit in the intervention group and has even hinted at possible harm caused by the intervention. A major limitation of this study is the low number of interventions performed in participating trauma centres and the associated potentially insufficient experience with REBOA.

The aim of this study is to evaluate the effectiveness of REBOA in a setting with already experienced providers.

Conditions

  • Hemorrhage
  • Shock, Traumatic
  • Cardiac Arrest Due to Trauma
  • Polytrauma

Interventions

PROCEDURE

Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA)

Temporary aortic occlusion can limit haemorrhage, can help to maintain perfusion to the heart and brain, and may be associated with improved survival.

Sponsors & Collaborators

  • Medical University of Graz

    lead OTHER

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2023-10-01
Completion
2024-12-20

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06312436 on ClinicalTrials.gov